These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15943757)

  • 1. Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig.
    Chilcott RP; Dalton CH; Hill I; Davison CM; Blohm KL; Clarkson ED; Hamilton MG
    Basic Clin Pharmacol Toxicol; 2005 Jul; 97(1):35-8. PubMed ID: 15943757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig.
    Chilcott RP; Dalton CH; Hill I; Davison CM; Blohm KL; Clarkson ED; Hamilton MG
    Hum Exp Toxicol; 2005 Jul; 24(7):347-52. PubMed ID: 16119248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.
    Lydon H; Hall C; Matar H; Dalton C; Chipman JK; Graham JS; Chilcott RP
    J Appl Toxicol; 2018 Mar; 38(3):318-328. PubMed ID: 29023806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination.
    Hamilton MG; Hill I; Conley J; Sawyer TW; Caneva DC; Lundy PM
    Mil Med; 2004 Nov; 169(11):856-62. PubMed ID: 15605929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
    Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
    Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
    Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
    Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro.
    Dalton CH; Hattersley IJ; Rutter SJ; Chilcott RP
    Toxicol In Vitro; 2006 Dec; 20(8):1532-6. PubMed ID: 16904285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo toxicological studies of V nerve agents: molecular and stereoselective aspects.
    Reiter G; Müller S; Hill I; Weatherby K; Thiermann H; Worek F; Mikler J
    Toxicol Lett; 2015 Jan; 232(2):438-48. PubMed ID: 25448275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of selected skin decontaminant products and regimens against VX in domestic swine.
    Bjarnason S; Mikler J; Hill I; Tenn C; Garrett M; Caddy N; Sawyer TW
    Hum Exp Toxicol; 2008 Mar; 27(3):253-61. PubMed ID: 18650258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrylcholinesterase in guinea pig lung lavage: a novel biomarker to assess lung injury following inhalation exposure to nerve agent VX.
    Graham JR; Wright BS; Rezk PE; Gordon RK; Sciuto AM; Nambiar MP
    Inhal Toxicol; 2006 Jun; 18(7):493-500. PubMed ID: 16603480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig.
    Chilcott RP; Dalton CH; Hill I; Davidson CM; Blohm KL; Hamilton MG
    Hum Exp Toxicol; 2003 May; 22(5):255-61. PubMed ID: 12774888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous penetration and distribution of VX using in vitro pig or human excised skin validation of demeton-S-methyl as adequate simulant for VX skin permeation investigations.
    Vallet V; Cruz C; Licausi J; Bazire A; Lallement G; Boudry I
    Toxicology; 2008 Apr; 246(1):73-82. PubMed ID: 18294748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality.
    Duysen EG; Li B; Xie W; Schopfer LM; Anderson RS; Broomfield CA; Lockridge O
    J Pharmacol Exp Ther; 2001 Nov; 299(2):528-35. PubMed ID: 11602663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration.
    van der Schans MJ; Lander BJ; van der Wiel H; Langenberg JP; Benschop HP
    Toxicol Appl Pharmacol; 2003 Aug; 191(1):48-62. PubMed ID: 12915103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining a threshold sub-acute dose leading to minimal physiological alterations following prolonged exposure to the nerve agent VX in rats.
    Bloch-Shilderman E; Rabinovitz I; Egoz I; Yacov G; Allon N; Nili U
    Arch Toxicol; 2018 Feb; 92(2):873-892. PubMed ID: 29127449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Russian VX: inhibition and reactivation of acetylcholinesterase compared with VX agent.
    Kuca K; Jun D; Cabal J; Hrabinova M; Bartosova L; Opletalova V
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):389-94. PubMed ID: 16623863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Catch-up" therapy: combining antidotal treatment with dermal application of AHA following percutaneous VX poisoning in the domestic swine.
    Bloch-Shilderman E; Nili U; Nahum V; Smolkin B; Ashkenazi N
    Arch Toxicol; 2023 Oct; 97(10):2771-2783. PubMed ID: 37610476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted chemical warfare agent VX toxicity to uniformed soldier using parathion in vitro human skin exposure and absorption.
    Wester RM; Tanojo H; Maibach HI; Wester RC
    Toxicol Appl Pharmacol; 2000 Oct; 168(2):149-52. PubMed ID: 11032770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX.
    Dorandeu F; Foquin A; Briot R; Delacour C; Denis J; Alonso A; Froment MT; Renault F; Lallement G; Masson P
    Toxicology; 2008 Jun; 248(2-3):151-7. PubMed ID: 18450356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity and median effective doses of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig.
    Snider TH; Babin MC; Jett DA; Platoff GE; Yeung DT
    J Toxicol Sci; 2016; 41(4):511-21. PubMed ID: 27432237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.